| Autor: |
Coenen EA; Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands., Zwaan CM; 1] Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands [2] Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands., Stary J; Pediatric Hematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Baruchel A; Pediatric Hematology, Hôpital Robert Debré AP-HP and University ParisDiderot, Paris, France., de Haas V; Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands., Stam RW; Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands., Reinhardt D; AML-BFM Study Group, Hannover, Germany., Kaspers GJ; Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, The Netherlands., Arentsen-Peters ST; Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands., Meyer C; Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia (DCAL), Frankfurt, Germany., Marschalek R; Institute of Pharmaceutical Biology, ZAFES, Diagnostic Center of Acute Leukemia (DCAL), Frankfurt, Germany., Nigro LL; Center of Pediatric Hematology Oncology, Azienda Policlinico, Catania, Italy., Dworzak M; St Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria., Pieters R; 1] Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands [2] Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands., van den Heuvel-Eibrink MM; 1] Pediatric Oncology/Hematology, Erasmus MC/Sophia Children's Hospital, Rotterdam, The Netherlands [2] Dutch Childhood Oncology Group (DCOG), The Hague, The Netherlands. |
